Repligen Corporation NASDAQ:RGEN

Repligen stock price today

$123.5
-22.03
-15.14%
Financial Health
0
1
2
3
4
5
6
7
8
9

Repligen stock price monthly change

+15.58%
month

Repligen stock price quarterly change

+15.58%
quarter

Repligen stock price yearly change

-20.78%
year

Repligen key metrics

Market Cap
8.07B
Enterprise value
9.34B
P/E
52.27
EV/Sales
11.66
EV/EBITDA
34.46
Price/Sales
11.78
Price/Book
4.94
PEG ratio
1.19
EPS
0.26
Revenue
607.45M
EBITDA
27.33M
Income
14.84M
Revenue Q/Q
-17.14%
Revenue Y/Y
-21.90%
Profit margin
23.2%
Oper. margin
28.03%
Gross margin
56.85%
EBIT margin
28.03%
EBITDA margin
4.5%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Repligen stock price history

Repligen stock forecast

Repligen financial statements

Average Price Target
Last Year

$201.67

Potential upside: 63.29%

Based on estimate of 3 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Repligen Corporation (NASDAQ:RGEN): Profit margin
Jun 2023 159.16M 20.06M 12.61%
Sep 2023 141.19M 18.17M 12.87%
Dec 2023 155.74M -25.48M -16.37%
Mar 2024 151.34M 2.09M 1.38%
Repligen Corporation (NASDAQ:RGEN): Debt to assets
Jun 2023 2549003000 578.07M 22.68%
Sep 2023 2514129000 525.57M 20.9%
Dec 2023 2824411000 853.20M 30.21%
Mar 2024 2849269000 878.66M 30.84%
Repligen Corporation (NASDAQ:RGEN): Cash Flow
Jun 2023 34.46M 64.83M -8.82M
Sep 2023 39.23M -8.77M -778K
Dec 2023 29.06M -169.90M 268.12M
Mar 2024 44.70M -8.36M -8.97M

Repligen alternative data

Repligen Corporation (NASDAQ:RGEN): Employee count
Aug 2023 2,025
Sep 2023 2,025
Oct 2023 2,025
Nov 2023 2,025
Dec 2023 2,025
Jan 2024 2,025
Feb 2024 2,025
Mar 2024 1,783
Apr 2024 1,783
May 2024 1,783
Jun 2024 1,783
Jul 2024 1,783

Repligen other data

100.00% +15.85%
of RGEN is owned by hedge funds
49.78M +1.59M
shares is hold by hedge funds

Repligen Corporation (NASDAQ:RGEN): Insider trades (number of shares)
Period Buy Sel
Feb 2024 0 5373
Mar 2024 0 20224
May 2024 0 20072
Jun 2024 4815 0
Aug 2024 0 11613
Sep 2024 0 22191
Nov 2024 0 24246
Transaction Date Insider Security Shares Price per share Total value Source
Option
HUNT ANTHONY director Common Stock 11,808 $33.87 $399,937
Option
HUNT ANTHONY director Stock Option (Right to Buy) 11,808 $33.87 $399,937
Option
HUNT ANTHONY director Common Stock 24,246 $33.87 $821,212
Sale
HUNT ANTHONY director Common Stock 24,246 $139.67 $3,386,439
Option
HUNT ANTHONY director Stock Option (Right to Buy) 24,246 $33.87 $821,212
Option
MUIR GLENN P director
Common Stock 19,000 $36.29 $689,510
Option
MUIR GLENN P director
Stock Option (Right to Buy) 19,000 $36.29 $689,510
Option
HUNT ANTHONY director Common Stock 10,000 $33.87 $338,700
Sale
HUNT ANTHONY director Common Stock 1,495 $143.77 $214,936
Sale
HUNT ANTHONY director Common Stock 9,369 $144.88 $1,357,381
Patent
Application
Filling date: 24 May 2022 Issue date: 8 Sep 2022
Grant
Filling date: 8 Sep 2020 Issue date: 6 Sep 2022
Grant
Filling date: 8 Sep 2020 Issue date: 30 Aug 2022
Application
Filling date: 16 Feb 2022 Issue date: 25 Aug 2022
Application
Filling date: 26 Apr 2022 Issue date: 11 Aug 2022
Application
Filling date: 5 Apr 2022 Issue date: 21 Jul 2022
Grant
Filling date: 20 Sep 2018 Issue date: 19 Jul 2022
Grant
Filling date: 14 Aug 2020 Issue date: 12 Jul 2022
Application
Filling date: 9 Mar 2022 Issue date: 23 Jun 2022
Application
Filling date: 8 Feb 2022 Issue date: 26 May 2022
Monday, 16 December 2024
prnewswire.com
Thursday, 12 December 2024
zacks.com
globenewswire.com
Monday, 9 December 2024
globenewswire.com
Tuesday, 12 November 2024
seekingalpha.com
zacks.com
benzinga.com
zacks.com
seekingalpha.com
Tuesday, 5 November 2024
globenewswire.com
Tuesday, 22 October 2024
zacks.com
Monday, 14 October 2024
globenewswire.com
Tuesday, 24 September 2024
globenewswire.com
Friday, 23 August 2024
globenewswire.com
Friday, 16 August 2024
reuters.com
Friday, 2 August 2024
fool.com
Wednesday, 31 July 2024
benzinga.com
zacks.com
Tuesday, 30 July 2024
seekingalpha.com
benzinga.com
zacks.com
globenewswire.com
Monday, 29 July 2024
globenewswire.com
Tuesday, 23 July 2024
zacks.com
Tuesday, 16 July 2024
globenewswire.com
Monday, 24 June 2024
zacks.com
Friday, 21 June 2024
benzinga.com
Friday, 14 June 2024
zacks.com
Thursday, 13 June 2024
globenewswire.com
Monday, 3 June 2024
businesswire.com
  • What's the price of Repligen stock today?

    One share of Repligen stock can currently be purchased for approximately $123.5.

  • When is Repligen's next earnings date?

    Unfortunately, Repligen's (RGEN) next earnings date is currently unknown.

  • Does Repligen pay dividends?

    No, Repligen does not pay dividends.

  • How much money does Repligen make?

    Repligen has a market capitalization of 8.07B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 20.31% to 638.76M US dollars.

  • What is Repligen's stock symbol?

    Repligen Corporation is traded on the NASDAQ under the ticker symbol "RGEN".

  • What is Repligen's primary industry?

    Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.

  • How do i buy shares of Repligen?

    Shares of Repligen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Repligen's key executives?

    Repligen's management team includes the following people:

    • Mr. Anthony J. Hunt Chief Executive Officer, Pres & Director(age: 61, pay: $1,110,000)
    • Mr. Jon K. Snodgres Chief Financial Officer(age: 59, pay: $693,790)
    • Mr. Ralf Kuriyel Senior Vice President of R&D(age: 66, pay: $645,250)
  • How many employees does Repligen have?

    As Jul 2024, Repligen employs 1,783 workers.

  • When Repligen went public?

    Repligen Corporation is publicly traded company for more then 39 years since IPO on 29 Apr 1986.

  • What is Repligen's official website?

    The official website for Repligen is repligen.com.

  • Where are Repligen's headquarters?

    Repligen is headquartered at Building 1, Waltham, MA.

  • How can i contact Repligen?

    Repligen's mailing address is Building 1, Waltham, MA and company can be reached via phone at +7 812500111.

  • What is Repligen stock forecast & price target?

    Based on 3 Wall Street analysts` predicted price targets for Repligen in the last 12 months, the avarage price target is $201.67. The average price target represents a 63.29% change from the last price of $123.5.

Repligen company profile:

Repligen Corporation

repligen.com
Exchange:

NASDAQ

Full time employees:

1,783

Industry:

Medical - Instruments & Supplies

Sector:

Healthcare

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Building 1
Waltham, MA 02453

CIK: 0000730272
ISIN: US7599161095
CUSIP: 759916109